These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 16142442)
1. Estrogen metabolizing polymorphisms and breast cancer risk among older white women. Modugno F; Zmuda JM; Potter D; Cai C; Ziv E; Cummings SR; Stone KL; Morin PA; Greene D; Cauley JA Breast Cancer Res Treat; 2005 Oct; 93(3):261-70. PubMed ID: 16142442 [TBL] [Abstract][Full Text] [Related]
2. Possible risk modification by polymorphisms of estrogen metabolizing genes in familial breast cancer susceptibility in an Indian population. Syamala VS; Syamala V; Sheeja VR; Kuttan R; Balakrishnan R; Ankathil R Cancer Invest; 2010 Mar; 28(3):304-11. PubMed ID: 19863350 [TBL] [Abstract][Full Text] [Related]
3. Impact of CYP1A1 and COMT genotypes on breast cancer risk in Mexican women: a pilot study. Moreno-Galván M; Herrera-González NE; Robles-Pérez V; Velasco-Rodríguez JC; Tapia-Conyer R; Sarti E Int J Biol Markers; 2010; 25(3):157-63. PubMed ID: 20878621 [TBL] [Abstract][Full Text] [Related]
4. Soy isoflavones, CYP1A1, CYP1B1, and COMT polymorphisms, and breast cancer: a case-control study in southwestern China. Wang Q; Li H; Tao P; Wang YP; Yuan P; Yang CX; Li JY; Yang F; Lee H; Huang Y DNA Cell Biol; 2011 Aug; 30(8):585-95. PubMed ID: 21438753 [TBL] [Abstract][Full Text] [Related]
5. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. Huang CS; Chern HD; Chang KJ; Cheng CW; Hsu SM; Shen CY Cancer Res; 1999 Oct; 59(19):4870-5. PubMed ID: 10519398 [TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of estrogen synthesizing and metabolizing genes and breast cancer risk in Japanese women. Miyoshi Y; Noguchi S Biomed Pharmacother; 2003 Dec; 57(10):471-81. PubMed ID: 14637391 [TBL] [Abstract][Full Text] [Related]
7. Lack of association between catechol-O-methyltransferase Val108/158Met polymorphism and breast cancer risk: a meta-analysis of 25,627 cases and 34,222 controls. Mao C; Wang XW; Qiu LX; Liao RY; Ding H; Chen Q Breast Cancer Res Treat; 2010 Jun; 121(3):719-25. PubMed ID: 20464630 [TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms in estrogen-metabolizing genes and breast cancer survival. Long JR; Cai Q; Shu XO; Cai H; Gao YT; Zheng W Pharmacogenet Genomics; 2007 May; 17(5):331-8. PubMed ID: 17429315 [TBL] [Abstract][Full Text] [Related]
9. Estrogen-metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women. Hefler LA; Tempfer CB; Grimm C; Lebrecht A; Ulbrich E; Heinze G; Leodolter S; Schneeberger C; Mueller MW; Muendlein A; Koelbl H Cancer; 2004 Jul; 101(2):264-9. PubMed ID: 15241822 [TBL] [Abstract][Full Text] [Related]
10. Association of single nucleotide polymorphisms in CYP1B1 and COMT genes with breast cancer susceptibility in Indian women. Yadav S; Singhal NK; Singh V; Rastogi N; Srivastava PK; Singh MP Dis Markers; 2009; 27(5):203-10. PubMed ID: 20037207 [TBL] [Abstract][Full Text] [Related]
11. Association of estrogen receptor alpha polymorphisms with breast cancer risk in older Caucasian women. Modugno F; Zmuda JM; Potter D; Cai C; Ziv E; Cummings SR; Stone KL; Morin PA; Greene D; Cauley JA Int J Cancer; 2005 Oct; 116(6):984-91. PubMed ID: 15856463 [TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in genes involved in the estrogen pathway and mammographic density. Dumas I; Diorio C BMC Cancer; 2010 Nov; 10():636. PubMed ID: 21092186 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of breast cancer risk in a multigenic model including low penetrance genes involved in xenobiotic and estrogen metabolisms. Delort L; Satih S; Kwiatkowski F; Bignon YJ; Bernard-Gallon DJ Nutr Cancer; 2010; 62(2):243-51. PubMed ID: 20099199 [TBL] [Abstract][Full Text] [Related]
14. [Relation between single nucleotide polymorphism in estrogen-metabolizing genes COMT, CYP17 and breast cancer risk among Chinese women]. Tan W; Qi J; Xing DY; Miao XP; Pan KF; Zhang L; Lin DX Zhonghua Zhong Liu Za Zhi; 2003 Sep; 25(5):453-6. PubMed ID: 14575568 [TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 1B1 and catechol-O-methyltransferase genetic polymorphisms and breast cancer risk in Chinese women: results from the shanghai breast cancer study and a meta-analysis. Wen W; Cai Q; Shu XO; Cheng JR; Parl F; Pierce L; Gao YT; Zheng W Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):329-35. PubMed ID: 15734954 [TBL] [Abstract][Full Text] [Related]
16. Genetic susceptibility of catechol-O-methyltransferase polymorphism in Japanese patients with breast cancer. Inoue H; Shibuta K; Matsuyama A; Yoshinaga K; Sadanaga N; Ueo H; Barnard GF; Mori M Oncol Rep; 2005 Sep; 14(3):707-12. PubMed ID: 16077979 [TBL] [Abstract][Full Text] [Related]
17. CYP17, catechol-o-methyltransferase, and glutathione transferase M1 genetic polymorphisms, lifestyle factors, and breast cancer risk in women on Prince Edward Island. Cribb AE; Joy Knight M; Guernsey J; Dryer D; Hender K; Shawwa A; Tesch M; Saleh TM Breast J; 2011; 17(1):24-31. PubMed ID: 21129090 [TBL] [Abstract][Full Text] [Related]
18. Association of COMT haplotypes and breast cancer risk in caucasian women. Peterson NB; Trentham-Dietz A; Garcia-Closas M; Newcomb PA; Titus-Ernstoff L; Huang Y; Chanock SJ; Haines JL; Egan KM Anticancer Res; 2010 Jan; 30(1):217-20. PubMed ID: 20150638 [TBL] [Abstract][Full Text] [Related]
19. COMT Val158Met polymorphism and breast cancer risk: evidence from 26 case-control studies. Ding H; Fu Y; Chen W; Wang Z Breast Cancer Res Treat; 2010 Aug; 123(1):265-70. PubMed ID: 20130981 [TBL] [Abstract][Full Text] [Related]
20. The catechol-O-methyltransferase (COMT) gene polymorphism and prevalence of uterine fibroids. de Oliveira E; de Aquino Castro R; Gomes MT; da Silva ID; Baracat EC; de Lima GR; Sartori MG; Girão MJ Maturitas; 2008; 60(3-4):235-8. PubMed ID: 18752908 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]